Hemochromatosis genotypes and risk of 31 disease endpoints: Meta-analyses including 66,000 cases and 226,000 controls

Hepatology

Volumn 46, Issue 4, 2007, Pages 1071-1080

  Ellervik, Christina ^a   Birgens, Henrik ^a   Tybjaerg Hansen, Anne ^b   Nordestgaard, Børge G ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ARTHRITIS; ARTICLE; CANCER; CLINICAL TRIAL; DIABETES MELLITUS; DISEASE ASSOCIATION; EUROPE; GENE MUTATION; GENOTYPE; HEART DISEASE; HEMOCHROMATOSIS; HUMAN; LIVER DISEASE; META ANALYSIS; NONALCOHOLIC FATTY LIVER; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; RISK FACTOR; STROKE; SYSTEMATIC REVIEW; VEIN DISEASE;

CASE-CONTROL STUDIES; ENDPOINT DETERMINATION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEMOCHROMATOSIS; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LIVER DISEASES; LIVER NEOPLASMS; MEMBRANE PROTEINS; MUTATION; ODDS RATIO; RISK FACTORS;

EID: 36349010904     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21885     Document Type: Article

References (30)

1. Pietrangelo A. Hereditary hemochromatosis - a new look at an old disease. N Engl J Med 2004;350:2383-2397.
2. Beutler E, Bothwell TH, Charlron RW, Motulsky AG. Hereditary hemochromatosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York, NY: McGraw-Hill; 2001:3127-3162.
3. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
4. Beutler E. Hemochromatosis: genetics and pathophysiology. Annu Rev Med 2006;57:331-347.
5. Ellervik C, Tybjaerg-Hansen A, Appleyard M, Sillesen H, Boysen G, Nordesrgaard BG. Hereditary hemochromatosis genotypes and risk of ischemic srroke. Neurology 2007;68:1025-1031.
6. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188.
7. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560.
8. Egger M, Smith GD, Altman DG. Systematic Reviews in Health Care. London, England: BMJ Books; 2003.
9. Bonkovsky HL, Troy N, McNeal K, Banner BF, Sharma A, Obando J, et al. Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C. J Hepatol 2002;37:848-854.
10. Powell EE, Ali A, Clouston AD, Dixon JL, Lincoln DJ, Purdie DM, et al. Steatosis is a cofactor in liver injury in hemochromatosis. Gastroenterology 2005;129:1937-1943.
11. Chitturi S, George J. Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis. Curr Gastroenterol Rep 2003;5:18-25.
12. Alla V, Bonkovsky HL. Iron in nonhemochromatotic liver disorders. Semin Liver Dis 2005;25:461-472.
13. Fargion S, Piperno A, Cappellini MD, Sampietro M, Fracanzani AL, Romano R, et al. Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association. HEPATOLOGY 1992;16:1322-1326.
14. Kordac V. Frequency of occurrence of hepatocellular carcinoma in patients with porphyria cutanea tarda in long-term follow-up. Neoplasma 1972;19:135-139.
15. Lee DW, Andersen JK, Kaur D. Iron dysregulation and neurodegeneration: the molecular connection. Mol Interv 2006;6:89-97.
16. Feder JN, Penny DM, Irrinki A, Lee VK, Lebron JA, Watson N, et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci U S A 1998;95:1472-1477.
17. Jones AC, Chuck AJ, Arie EA, Green DJ, Doherty M. Diseases associated with calcium pyrophosphate deposition disease. Semin Arthritis Rheum 1992;22:188-202.
18. Jager HJ, Mehring U, Gotz GF, Neise M, Erlemann R, Kapp HJ, et al. Radiological features of the visceral and skeletal involvement of hemochromatosis. Eur Radiol 1997;7:1199-1206.
19. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G-> a (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002;359:211-218.
20. Andersen RV, Tybjaerg-Hansen A, Appleyard M, Birgens H, Nordestgaard BG. Hemochromatosis mutations in the general popularion: iron overload progression rate. Blood 2004;103:2914-2919.
21. Juul K, Tybjaerg-Hansen A, Schnohr P, Nordestgaard BG. Factor V Leiden and the risk for venous thromboembolism in the adult Danish population. Ann Intern Med 2004;140:330-337.
22. Tybjaerg-Hansen A, Jensen HK, Benn M, Steffensen R, Jensen G, Nordestgaard BG. Phenotype of heterozygotes for low-density lipoprotein receptor mutations identified in different background populations. Arterioscler Thromb Vasc Biol 2005;25:211-215.
23. Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, et al. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 2005;352:1769-1778.
24. Smith GD, Ebrahim S. Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol 2004;33:30-42.
25. Halsall DJ, McFarlane I, Luan J, Cox TM, Wareham NJ. Typical type 2 diabetes mellitus and HFE gene mutations: a population-based case-control study. Hum Mol Genet 2003;12:1361-1365.
26. Qi L, Meigs J, Manson JE, Ma J, Hunter D, Rifai N, et al. HFE genetic variability, body iron stores, and the risk of type 2 diabetes in U.S. women. Diabetes 2005;54:3567-3572.
27. van der A DL, Peeters PH, Grobbee DE, Roest M, Marx JJ, Voorbij HM, et al. HFE mutations and risk of coronary heart disease in middle-aged women. Eur J Clin Invest 2006;36:682-690.
28. Guerreiro RJ, Bras JM, Santana I, Januario C, Santiago B, Morgadinho AS, et al. Association of HFE common mutations with Parkinson's disease, Alzheimer's disease and mild cognitive impaitment in a Portuguese cohort. BMC Neurol 2006;6:24.
29. Njajou OT, Alizadeh BZ, Vaessen N, Vergeer J, Houwing-Duistermaat J, Hofman A, et al. The role of hemochromatosis C282Y and H63D gene mutations in type 2 diabetes: findings from the Rotterdam study and meta-analysis. Diabetes Care 2002;25:2112-2113.
30. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al., for the Meta-Analysis of Observational Studies in Epidemiology Group. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000;283:2008-2012.